Current Opinion in Pulmonary Medicine

Article	Citations
Chronic obstructive pulmonary disease and COVID-19: interrelationships	56
Pulmonary pathology of COVID-19: a review of autopsy studies	47
A clinical review of long-COVID with a focus on the respiratory system	35
Drug-induced sarcoidosis-like reactions	29
COVID-19: vaccines, efficacy and effects on variants	26
Drug treatment of COVID-19 infection	24
New guidelines for severe community-acquired pneumonia	23
Genetics in sarcoidosis	22
The role of computed tomography scan in the diagnosis of COVID-19 pneumonia	21
Pleuroparenchymal fibroelastosis	20
Risk stratification of indeterminate pulmonary nodules	20
Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment	20
Telehealth and virtual health monitoring in cystic fibrosis	18
The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus	18
Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world – opportunities and challenges	17
The impact of fungal allergic sensitization on asthma	17
Impact of obesity on pulmonary function: current understanding and knowledge gaps	17
COVID-19 and other respiratory tract infections at mass gathering religious and sporting events	17
COVID-19 outcomes in people with cystic fibrosis	16
Upper airway muscles: influence on obstructive sleep apnoea pathophysiology and pharmacological and technical treatment options	16
Sarcoidosis and autoimmunity	16
Implementation of digital home monitoring and management of respiratory disease	16
Drug-resistant tuberculosis: advances in diagnosis and management	15
COVID-19: a new burden of respiratory disease among South African miners?	15
ICU preparedness in pandemics: lessons learned from the coronavirus disease-2019 outbreak	15

Nontuberculous mycobacteria in cystic fibrosis	14
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	14
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions	14
Update on sarcoidosis guidelines	14
Severe pulmonary toxicity associated with inhalation of pyrethroid-based domestic insecticides (Bop/Sapolio): a case series and literature review	14
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019	13
Obstructive lung diseases and allergic bronchopulmonary aspergillosis	13
The role of PET in the management of sarcoidosis	13
Robotic bronchoscopy and future directions of interventional pulmonology	13
COVID-19 new diagnostics development: novel detection methods for SARS-CoV-2 infection and considerations for their translation to routine use	12
Epidemiology and real-life experience in progressive pulmonary fibrosis	12
Airborne transmission of respiratory viruses including severe acute respiratory syndrome coronavirus 2	12
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	12
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	11
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	11
Rapid eye movement predominant obstructive sleep apnoea: prognostic relevance and clinical approach	11
Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic	11
Hit-hard and early versus step-up treatment in severe sarcoidosis	11
SMART - is it practical in the United States?	11
Vaping epidemic in US teens: problem and solutions	11
Robotic bronchoscopy for peripheral pulmonary lesions: a convergence of technologies	11
Unprecedented: the toxic synergism of Covid-19 and climate change	10
Pulmonary toxicity associated with occupational and environmental exposure to pesticides and herbicides	10
The evolving role of radiological imaging in cystic fibrosis	10
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?	10
Atypical mycobacterial infections – management and when to treat	10
Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly	10
Current practices in the management of central airway obstruction	10
Pulmonary adverse events following immune checkpoint inhibitors	10
Influenza: clinical aspects, diagnosis, and treatment	10
Lethal zoonotic coronavirus infections of humans – comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and se	9
At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease	9
Drug-induced comorbidities in patients with sarcoidosis	9
Biopsy in interstitial lung disease: specific diagnosis and the identification of the progressive fibrotic phenotype	9
Glymphatic MRI techniques in sleep and neurodegenerative diseases	9
The justification for the progressive fibrotic phenotype	9
Sarcoidosis associated pulmonary hypertension: an update	9
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: advances in patient and lesion selection	8
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021	8
Telerehabilitation in pulmonary diseases	8
Sleep medicine and coronavirus disease 2019	8
Bronchoscopic diagnosis of peripheral lung lesions	8
COVID-19 – pathogenesis and immunological findings across the clinical manifestation spectrum	8
COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes	8
Emerging clinical perspectives in cystic fibrosis liver disease	8
The progressive fibrotic phenotype in current clinical practice	7
Occupational exposures and sarcoidosis: current understanding and knowledge gaps	7
Sarcoidosis and maligancy: the chicken and the egg?	7
New pharmacologic agents for obstructive sleep apnoea: what do we know and what can we expect?	7
Recent advances in the management of systemic sclerosis-associated interstitial lung disease	7

Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	7
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective	7
Military deployment-related respiratory problems: an update	7
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	7
Respiratory viral infections in the immunocompromised	7
Home monitoring in asthma: towards digital twins	7
Management of pneumothorax: an update	6
Therapeutic bronchoscopy for malignant central airway obstruction: impact on quality of life and risk-benefit analysis	6
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators	6
Unclassifiable, or simply unclassified interstitial lung disease?	6
Lung cancer staging, the established role of bronchoscopy	6
Environmental and occupational exposures in interstitial lung disease	6
The different facets of sickle cell disease-related pulmonary hypertension	6
Cyclic alternating patterns and arousals: what is relevant in obstructive sleep apnea? In Memoriam Mario Giovanni Terzano	6
Malignant pleural disease: a pragmatic guide to diagnosis	6
Personalized medicine in sarcoidosis: unravelling biomarkers for targeted care	6
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	6
Advances in development of new tuberculosis vaccines	6
Transbronchial lung cryobiopsy for the diagnosis of interstitial lung diseases	6
Care of the postcoronavirus disease 2019 patient	6
Progress and challenges in fungal lung disease in cystic fibrosis	6
More than sleepiness: prevalence and relevance of nonclassical symptoms of obstructive sleep apnea	6
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	6
Sleep in the intensive care unit	6
Silica-associated lung disease in developing countries	6
Exhaled breath analysis in interstitial lung disease	5
Methamphetamine-associated pulmonary arterial hypertension	5
Eosinophilic respiratory disorders and the impact of biologics	5
Nutritional and metabolic management for cystic fibrosis in a post-cystic fibrosis transmembrane conductance modulator era	5
Diagnostic and therapeutic challenges of chronic obstructive pulmonary disease in the elderly	5
Recent advances in the genetics of idiopathic pulmonary fibrosis	5
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?	5
Host-directed therapies for COVID-19	5
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?	5
Management of immunosuppressants in the era of coronavirus disease-2019	5
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: DIPNECH	5
Telehealth and its implementation in respiratory sleep medicine	4
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	4
Quantitative computed tomography and machine learning: recent data in fibrotic interstitial lung disease and potential role in pulmonary sarcoidosis	4
Postpulmonary embolism syndrome	4
Pediatric sarcoidosis with diagnostic and therapeutical insights	4
Effectiveness and safety of coronavirus disease 2019 vaccines	4
Pulmonary alveolar proteinosis – current and future therapeutical strategies	4
The influence of age and sex in sarcoidosis	4
Ageing and chronic obstructive pulmonary disease: interrelationships	4
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	4
Interstitial lung disease following coronavirus disease 2019	4
Ageing with Interstitial lung disease: preserving health and well being	4
Home monitoring of coronavirus disease 2019 patients in different phases of disease	4
Advancements in airway stents: a comprehensive update	4
Current state and future potential of AI in occupational respiratory medicine	4
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	4
Advances in bronchoscopic optical coherence tomography and confocal laser endomicroscopy in pulmonary diseases	4
Organ involvement and assessment in sarcoidosis	3
Coronavirus disease 2019 management	3
Interrelationships between tuberculosis and chronic obstructive pulmonary disease	3
Evolving nonvasodilator treatment options for pulmonary arterial hypertension	3
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	3
Precision medicine in chronic obstructive pulmonary disease: how far have we come?	3
Remission in asthma	3
The role of primary care in sarcoidosis	3
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide	3
Editorial: Coronavirus disease 2019 (COVID-19) – advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges	3
Patterns of progression in non-IPF fibrotic interstitial lung disease	3
Thoracic computed tomography in the progressive fibrotic phenotype	3
How might endotyping guide chronic obstructive pulmonary disease treatment? Current understanding, knowledge gaps and future research needs	3
The prevalence of childhood asthma: interpreting falling rates in the context of shifting measurement and the COVID-19 pandemic	3
The emerging role of inorganic elements as potential antigens in sarcoidosis	3
Update on balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension	3
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice	3
Asbestos-associated pulmonary disease	3
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	3
The evolving paradigm of precision medicine in lung cancer	3
Novel insights in fibrotic pulmonary sarcoidosis	3
Genetic therapies in cystic fibrosis	3
Recent advances predict a bright future for nebulizers	3
Chronic hypersensitivity pneumonitis: real world diagnostic criteria	3
The controversy over daylight saving time: evidence for and against	3
Telemedicine and remote monitoring in cystic fibrosis	3
Current challenges and perspectives in lung cancer care during COVID-19 waves	3

Advances in inhaled antibiotics for management of respiratory tract infections	3
Indwelling pleural catheters for benign pleural effusions: a concise review	2
Chronic obstructive pulmonary disease and obstructive sleep apnoea overlap: co-existence, co-morbidity, or causality?	2
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	2
An update on hypersensitivity pneumonitis: what a clinician wants to know	2
Cystic fibrosis liver disease in the post-modulator era	2
Risk stratification and treatment of pulmonary embolism with intermediate-risk of mortality	2
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	2
Transcutaneous electrical stimulation in obstructive sleep apnoea: current developments and concepts of the TESLA-home programme	2
Disparities across the continuum of lung cancer care: a review of recent literature	2
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	2
Altered pharmacology and toxicology during ageing: implications for lung disease	2
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	2
Role of the internet of medical things in care for patients with interstitial lung disease	2
Myositis-associated interstitial lung disease	2
Vitamin D deficiency in chronic obstructive pulmonary disease	2
Toward targeted treatments for silicosis	2
Shifting gears: the search for group 3 pulmonary hypertension treatment	2
Group 2 pulmonary hypertension: from diagnosis to treatment	2
Telemedicine and home monitoring for COPD – a narrative review of recent literature	2
Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges	2
An update on bronchopleural fistulae following cancer-related surgery	2
Labelling and denominating lung toxicity effects of pesticides	2
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases	2
Updates in the diagnosis and management of chronic thromboembolic disease	2
As-needed inhaled corticosteroids as add-on therapy versus SMART therapy: an evolving understanding of the two approaches in the management of moderate-to-severe asthma	2
Management of fibrotic hypersensitivity pneumonitis	2
Risk stratification of pulmonary embolism	2